Physician profile
Amanda N Dillon
NPI 1649754474
$546.97
in general payments reported to CMS, 2019-2025
14 companies · $31.12 in 2025
The $31.12 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $181 · 2023: $119 · 2024: $14.94 · 2025: $31.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $298.54 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.67 | 2023 | Xifaxan, Plenvu |
| Merck Sharp & Dohme LLC | $26.45 | 2021-2023 | Verquvo |
| Abbvie INC. | $24.93 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.55 | 2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $17.26 | 2025 | |
| Resmed Corp | $17.17 | 2022 | |
| Mylan Specialty L.P. | $16.18 | 2023 | Yupelri |
| Novo Nordisk INC | $14.94 | 2024 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $14.61 | 2021 | |
| Genzyme Corporation | $14.34 | 2021 | |
| Inspire Medical Systems, INC. | $13.86 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.86 | 2021 | |
| Janssen Biotech, INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.